A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old | MicrobiomeTrials← Back to trialsNCT06944717
A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2025-03-03Est. Completion: 2026-04-14
Enrollment target: 60 participants Locations- Johnson County Clin Trials - JCCT, Lenexa, Kansas, United States
Other microbiome trials you might be interested in
Anogenital HerpesCOVID-19Herpes Labialis
Background:
\- Viral infections are an important cause of illness and death in hospitalized patients as well as outpati…
Bethesda, United States
PneumoniaFungal PneumoniaAspergillosis PneumoniaPulmonary AspergillosisPulmonary Aspergillosis InvasivePneumocystisPneumocystis PneumoniaFungal DiseaseFungal Infection
Fungal Infection Lungs
The FUNGAL-P study is a single-center observational study designed to derive and validate a clinical prediction score fo…
Florence, ItalyEst. completion Nov 13, 2030